Labophar
0643.723.177 · rovalta.com · 23/09/2026
ACTIVE
Labophar (SA)
Financial year 2025 · closed on 31/12/2025
Net result
-375,7 k €
+10.1% YoY
Revenue
406,7 k €
-0.2% YoY
Equity
2,5 M €
-13.2% YoY
Overview
What does Labophar do?
Labophar is a Public limited company incorporated in 2015. Its main activity is: Buying and selling of own real estate. Its registered office is in Gent.
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0643.723.177
Incorporation
30/11/2015
Legal form
Public limited company
Registered office
Kortrijksesteenweg 1091 box B
9051 Gent · FlandreSee on map
9051 Gent · FlandreSee on map
Contributed capital
4 610 613,72 €
Latest accounts
31/12/2025
Activities (NACE)
Joint committees (2)
- 207
- 2070
Signals
Positive cashflowPositive EBITDA
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 10 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||
| Revenue | 406,7 k € | -0.2% | 407,5 k € | -72.4% | 1,5 M € | -66.5% | 4,4 M € | -2.6% | 4,5 M € | +180% | 1,6 M € | +259% | 450 k € | – | 538,2 k € | +741% | 64 k € | ||
| EBITDA | 419,8 k € | -4.0% | 437,1 k € | +279% | 115,2 k € | -68.0% | 359,9 k € | -10.0% | 399,7 k € | +634% | 54,5 k € | -25.2% | 72,8 k € | -27.3% | 100,2 k € | -56.4% | 229,9 k € | +387% | 47,2 k € |
| Operating result | -117,6 k € | +5.8% | -124,8 k € | +40.5% | -209,6 k € | +23.5% | -274,2 k € | -412% | -53,5 k € | -406% | 17,5 k € | -35.9% | 27,3 k € | -59.7% | 67,8 k € | -64.9% | 192,8 k € | +333% | 44,5 k € |
| Net result | -375,7 k € | +10.1% | -417,9 k € | +9.8% | -463,1 k € | +9.4% | -511,3 k € | -25.5% | -407,3 k € | -2168% | -18 k € | -277% | -4,8 k € | -114% | 35,3 k € | -71.9% | 125,6 k € | +165% | 47,3 k € |
| Balance sheet | |||||||||||||||||||
| Equity | 2,5 M € | -13.2% | 2,9 M € | -12.8% | 3,3 M € | -12.4% | 3,7 M € | -12.0% | 4,2 M € | -11.5% | 4,8 M € | -0.4% | 4,8 M € | +11.5% | 4,3 M € | +3.5% | 4,2 M € | +3.1% | 4 M € |
| Total assets | 8,6 M € | +0.4% | 8,6 M € | -2.2% | 8,8 M € | -21.2% | 11,2 M € | -2.6% | 11,5 M € | +54.2% | 7,4 M € | +7.9% | 6,9 M € | -0.9% | 7 M € | -5.5% | 7,4 M € | -26.8% | 10,1 M € |
| Cash | – | – | 0 € | -100% | 313 k € | -13.4% | 361,2 k € | +546% | 56 k € | -57.3% | 131 k € | -81.5% | 707,6 k € | -57.9% | 1,7 M € | +293% | 428,3 k € | ||
| Debts | 6 M € | +8.3% | 5,5 M € | +3.9% | 5,3 M € | -25.9% | 7,1 M € | +2.3% | 7 M € | +190% | 2,4 M € | +16.7% | 2,1 M € | -21.9% | 2,6 M € | -17.3% | 3,2 M € | -46.9% | 6 M € |
| Other | |||||||||||||||||||
| Workforce | – | – | 0,0 ETP | -100% | 11,7 ETP | -10.7% | 13,1 ETP | +48.9% | 8,8 ETP | +22.2% | 7,2 ETP | +500% | 1,2 ETP | – | – | ||||
Estimate
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2025 · 3 active · 26 ended
Active mandates
Ended mandates
At this address
Other companies at this address
| Company | CBE no. |
|---|---|
2PHARMA● Active | 0886.662.746 |
2PHARMA HOLDING● Active | 0644.751.377 |
b+pharma Belgium● Active | 0474.817.869 |
BTW-eenheid Ter Beke● Active | 0893.541.630 |
Ceres Invest● Active | 0775.683.264 |
Ceres Pharma● Active | 0641.953.324 |
Ceres Pharmaceuticals● Active | 0407.326.754 |
CONESSENCE● Active | 0819.266.552 |
Conessence Engineering● Active | 0794.812.555 |
CONESSENCE FINANCIAL RECRUITMENT● Active | 0681.915.443 |
CREDOPHAR● Active | 0849.730.193 |
DGPharma● Active | 0508.925.544 |
DRIEPUNTNUL● Active | 1021.711.292 |
HR ESSENTIALS● Active | 0721.702.467 |
KOUTERLOS● Active | 0450.036.349 |
MD Pharma● Active | 0667.779.672 |
PADEL FACTORY● Active | 0801.951.260 |
| 0865.651.952 | |
What’s Cooking Belgium● Active | 0884.649.304 |
What's Cooking Group● Active | 0421.364.139 |
Financials
Annual accounts
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/06/2026 | 22/07/2025 | 08/07/2024 | 31/08/2023 | 11/07/2022 | 19/07/2021 |
| General meeting | 15/06/2026 | 16/06/2025 | 17/06/2024 | 19/06/2023 | 20/06/2022 | 21/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
11 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 15/06/2026 | 30/06/2026 | Dutch | |
| Full model | 31/12/2024 | 16/06/2025 | 22/07/2025 | Dutch | |
| Full model | 31/12/2023 | 17/06/2024 | 08/07/2024 | Dutch | |
| Full model | 31/12/2022 | 19/06/2023 | 31/08/2023 | Dutch | |
| Full model | 31/12/2021 | 20/06/2022 | 11/07/2022 | Dutch | |
| Full model | 31/12/2020 | 21/06/2021 | 19/07/2021 | Dutch | |
| Full model | 31/12/2019 | 27/08/2020 | 10/09/2020 | Dutch | |
| Full model | 31/12/2018 | 18/09/2019 | 27/09/2019 | Dutch | |
| Abridged model | 31/12/2017 | 31/01/2018 | 28/02/2018 | Dutch | |
| Abridged model | 31/12/2016 | 05/06/2017 | 14/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 23/05/2016 | 23/08/2016 | Dutch |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2025 · 3 active · 26 ended
Active mandates
Ended mandates
Shareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
- Registered office24/02/2023MAATSCHAPPELIJKE ZETEL
- Mandates12/12/2022MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
- Mandates24/12/2021ONTSLAGEN - BENOEMINGEN
- Restructuring21/09/2020RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Restructuring28/07/2020STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Restructuring28/07/2020ALGEMENE VERGADERING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Restructuring16/07/2020RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Restructuring13/05/2020RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-375,7 k €↑
- 2024Annual accounts 2024-417,9 k €↑
- 2023Annual accounts 2023-463,1 k €↑
- 2022Annual accounts 2022-511,3 k €↓
- 2021Annual accounts 2021-407,3 k €↓
- 2019Annual accounts 2019-18 k €↓
- 2018Annual accounts 2018-4,8 k €↓
- 2017Annual accounts 201735,3 k €↓
- 2016Annual accounts 2016125,6 k €↑
- 2015Annual accounts 201547,3 k €
- 30/11/2015IncorporationPublic limited company